Skip to content

enVista® Toric IOL MX60ET (REF MXUET275+190)Recalls & reported problems

Bausch & Lomb Incorporated · enVista one-piece hydrophobic acrylic toric intraocular lens +19.00D SE / +2.75D CYL · Class 3 · Implant

All models of enVista Toric IOL (450)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770556158), received between Jun 15, 2023 and Jun 15, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Unintended Movement” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Unintended Movement1

Patient problems

  • Blurred Vision1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 15, 2023Unintended Movement; Unintended Movement

    IT WAS REPORTED APPROXIMATELY TWO WEEKS AFTER IMPLANTATION OF AN INTRAOCULAR LENS INTO THE LEFT EYE (OS) THE LENS ROTATED OUT OF POSITION. LENS ROTATION WAS SCHEDULED FOR APPROXIMATELY SEVEN WEEKS AFTER INITIAL SURGERY. ADDITIONAL INFORMATION WAS REQUESTED, BUT NOT RECEIVED.

    Patient problems: Blurred Vision

    MAUDE report 17137583 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page